Longeveron names Marie Washburn CFO, replacing Lisa Locklear

Longeveron

Longeveron

LGVN

0.00
  • Longeveron named Marie Washburn senior vice president, chief financial officer, principal financial officer, principal accounting officer, effective July 13, 2026.
  • Washburn succeeds Lisa Locklear, who is stepping down to pursue board opportunities, professional interests, personal interests.
  • Washburn has been vice president, corporate controller since November 2025; previously led finance roles at Fore Biotherapeutics, Axcella Health, Generation Bio, Momenta Pharmaceuticals.
  • Management change comes ahead of top-line results expected in Q3 2026 from the Phase 2b HLHS trial of stem cell therapy laromestrocel.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Longeveron Inc. published the original content used to generate this news brief on July 06, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.